NBC Washington1mon
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
Eli Lilly's ... weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as both medicines have largely recovered from widespread ...
BioSpace13d
FDA Still Undecided About Shortage Status of Lilly’s Tirzepatide
Pending the FDA’s decision, compounding pharmacies will remain free to make and market versions of the blockbuster ...
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
Amgen's new obesity drug, MariTide, shows promise against giants Eli Lilly and Novo Nordisk, but faces tough competition in a ...
Hosted on MSN2mon
Eli Lilly’s Weight-Loss Drugs Are No Longer in Short Supply. Bad News for Hims & Hers.
Eli Lilly’s blockbuster obesity and diabetes drugs Zepbound and Mounjaro are no longer ... The shortage of the drug tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight ...
Eli Lilly’s Obesity Drug Set for Slow NHS Rollout in England
England’s National Health Service will begin rolling out Eli Lilly & Co.’s blockbuster weight-loss drug Mounjaro over the ...